#eps-miss
Latest news and interesting information about eps-miss.
Karyopharm Q1 2026: EPS Miss, Stock Drops
Karyopharm Q1 2026 EPS miss of -$1.24 vs -$0.09 expected leads to 13.33% stock drop. Revenue up 17% but guidance reaffirmed.
Ovintiv Q1 2026: Revenue beats, EPS misses forecasts
Ovintiv Q1 2026 results: revenue beat, EPS miss, stock rise. Company focuses on shareholder returns and operational efficiency.
ORIX Q4 2026: Revenue record, EPS misses forecasts
ORIX Q4 2026 results: revenue beats forecasts, EPS misses. Company posts record net income, raises buyback and dividend targets.
...


